IMPL
Impel Pharmaceuticals Inc
$0.43
Earnings Summary
Revenue | $6.58Mn |
Net Profits | $-7.36Mn |
Net Profit Margins | -111.74% |
Highlights
Impel Pharmaceuticals Inc’s revenue jumped 134.89% since last year same period to $6.58Mn in the Q2 2023. On a quarterly growth basis, Impel Pharmaceuticals Inc has generated 50.59% jump in its revenue since last 3-months.
Impel Pharmaceuticals Inc’s net profit jumped 70.81% since last year same period to $-7.36Mn in the Q2 2023. On a quarterly growth basis, Impel Pharmaceuticals Inc has generated 80.96% jump in its net profits since last 3-months.
Impel Pharmaceuticals Inc’s net profit margin jumped 87.57% since last year same period to -111.74% in the Q2 2023. On a quarterly growth basis, Impel Pharmaceuticals Inc has generated 87.35% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Impel Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.52 |
EPS Estimate Current Year | -0.52 |
Highlights
Impel Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.52 - a 12.61% jump from last quarter’s estimates.
Impel Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.52.
Key Ratios
Key ratios of the Impel Pharmaceuticals Inc post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Impel Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Impel Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-18 | -0.6 | 0 | 100% |
2023-11-13 | -0.52 | 0 | 100% |
2023-05-12 | -0.98 | 0 | 100% |
₹0 US Stocks a/c Opening Fee